Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Thyroid Diseases

• A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer
• A Multicenter, Open-label Extension Study Evaluating the Efficacy and Safety of IBI311 in Subjects With Thyroid Eye Disease
• A Phase 2b Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
• A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease (SatraGO-2)
• Thyroid Cancer and Central Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW
• A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 75 Years of Age With Thyroid Eye Disease
• Efficacy and Safety of Tocilizumab for TAO
• Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
• NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
• Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer
• A Randomized, Double-masked, Placebo-controlled Safety, Tolerability, and Efficacy Study of VRDN-001, a Humanized Monoclonal Antibody Directed Against the IGF-1 Receptor, in Participants With Chronic Thyroid Eye Disease (TED)
• A Study of Avutometinib and Defactinib in People With Thyroid Cancer
• Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
• A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Participants With Thyroid Eye Disease
• Pembrolizumab in High-risk Thyroid Cancer
• Prospective Comparison of the Effect on Antiadhesive Barriers During Thyroid or Parathyroid Surgery
• Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
• Comparative Study of Polidocanol and Absolute Alcohol for Percutaneous us Guided Treatment of Benign Thyroid Cyst
• A Phase 1 Study of BDTX-4933 in Patients With BRAF and Select RAS/MAPK Mutation Positive Cancers
• Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
• Study of ZB001 in Chinese Patients With Thyroid Eye Disease
• DETERMINE Trial Treatment Arm 5: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
• Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer
• Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)
• Efficacy and Safety of VB421 in Subjects With Thyroid Eye Disease (TED)
• A Study of TY-1091 in Patients With Advanced Solid Tumors
• Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC
• Cabozantinib In Advanced Radioactive-Iodine Refractory Differentiated Thyroid Cancer.
• PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer
• Measurement of Iodolipids in the Thyroid Gland and Other Biological Samples
• Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy
• Evaluation of the 18F-PSMA Positron Emission Tomography (PET)/CT in Patients With Medullary Thyroid Cancer
• Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
• Extension Study to Assess Batoclimab in Participants With Thyroid Eye Disease
• Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease
• Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma
• Bilateral Ultrasound Guided Superficial Cervical Plexus Block After Thyroid Surgery
• Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer
• Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone Metastases
• Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer
• Thyroid Associated Orbitopathy Treatment by Methotrexate Against Triamcinolone Periocular Injections
• Treatment Using 177Lu-DOTA-EB-FAPI in Patients With Radioactive Iodine Refractory Thyroid Cancer
• Metastatic Thyroid Cancer Therapy Optimization With 124I PET Dosimetry
• Ropivacaine Plus Magnesium Sulphate Infiltration
• A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
• Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer
• Effect of Exergaming Exercises and Mediterranean Diet on Thyroid Cancer Patients Following Total Thyroidectomy
• Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
• A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)
• Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.
• A Safety, Tolerability and Efficacy Study of VRDN 001 in Healthy Volunteers and Persons With Thyroid Eye Disease (TED)
• Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
• Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
• Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy
• Multi-model Image of Doxycycline in TAO
• Multi-model Image of Immunosuppressive Agents in TAO
• The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation
• IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC
• Comparison of Quality of Recovery (QoR)-15 Scores
• A Study to Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease
• Study on the Treatment of Differentiated Thyroid Carcinoma With Anlotinib
• TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study
• Effect of Tramadol on Postoperative Sore Throat After General Anesthesia
• A Randomized, Open-label Clinical Trial, Focus on the Safety and Efficacy of Anlotinib Hydrochloride in Combination With RAI in Patients With Local Advanced and Tyriod Cancer
• Study of Efficacy and Safety of Dabrafenib Plus Trametinib in Previously Treated Patients With Locally Advanced or Metastatic, Radio-active Iodine Refractory BRAFV600E Mutation-positive Differentiated Thyroid Cancer
• Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
• The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
• GFRα4 CAR T Cells in MTC Patients
• Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery
• Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
• A Study of HA121-28 Tablets in Patients With Medullary Thyroid Carcinoma (MTC)
• Contribution of ICG Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy
• Energy Metabolism in Thyroidectomized Patients
• A Study of Pralsetinib Versus Standard of Care (SOC) for Treatment of RET-Mutated Medullary Thyroid Cancer (MTC).
• Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
• Use of Prophylactic Steroids in the Prevention of Post-thyroidectomy Hypocalcaemia and Voice Dysfunction
• Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer
• A Study of the Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)
• Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer
• Thyroid Autotransplantation in Quadriceps Femoris Muscle
• Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma
• Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer
• A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
• Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
• Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer
• An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer Undergoing Radiation Therapy and/or Systemic Therapy
• Effect of Cervical Block on Recurrent Laryngeal Nerve Monitoring During Thyroid Surgery
• A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease
• Lidocaine And Neuromonitoring in Thyroid Surgery
• Study of HX008 for the Treatment of Anaplastic Thyroid Cancer (ATC)
• Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer
• Clinical Trial in RAI-Refractory Thyroid Carcinoma Evaluating BRAF & MEK Blockade for Re-differentiation Therapy
• Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
• PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
• Preoperative Steroids in Autoimmune Thyroid Disease
• Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study
• Multiple Target Kinase Inhibitor and Anti-Programmed Death-1 Antibody in Patients With Advanced Thyroid Cancer
• Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
• Topical Bupivacaine Effect On The Response To Awake Extubation During Emergence From General Anesthesia
• Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers
• The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.
• Bupivacaine Versus Lidocaine Infiltration for Postoperative Pain in Thyroid Surgery
• Tamsulosin for Thyroid Lid Retraction
• Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
• Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System
• Lenvatinib in Locally Advanced Invasive Thyroid Cancer
• Anti-VEGF Therapy for Acute Thyroid Eye Disease
• Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer
• Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes
• Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
• Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial
• A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation
• Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer
• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer
• Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers
• Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer
• Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients
• A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants
• Treatment of ARDS With Instilled T3
• Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers
• Vit D Role in Post Thyroidectomy Hypocalcemia
• Exparel Injection Effect on Postoperative Opioid Usage
• Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
• Bilateral Superficial Cervical Plexus Block in Thyroid/Parathyroid Surgery
• A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
• Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer
• Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment
• 99Tc-MDP for Thyroid-Associated Ophthalmopathy
• Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer
• The Improvement of Intraoperative Neuromonitoring of Recurrent Laryngeal Nerve
• Anaesthesia With or Without Rocuronium in Intubation and Intraoperative Nerve-monitoring During Thyroid Surgery.
• A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
• The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
• Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
• Systematic Administration of Calcium and Vitamin D After Thyroidectomy
• Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial
• Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas
• A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
• 177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer
• Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
• Pain Medications Following Thyroidectomy and Parathyroidectomy
• Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer
• A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer
• A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
• Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer
• Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring
• Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid Cancer
• Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (≥15 mm) Classified Bethesda III or IV on Cytology
• Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging
• Minimizing Narcotic Analgesics After Endocrine Surgery
• A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
• Gallium-68 Prostate Specific Membrane Antigen PET in Diagnosing Patients With Thyroid Cancer
• LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas
• Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
• PLD Combined With Cisplatin in the Treatment of Advanced Poorly Differentiated Thyroid Carcinoma
• Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors
• Efficacy of Dexmedetomidine for Cough Suppression in Patients Undergoing Thyroid Surgery
• Trail Evaluating Apatinib With IMRT for Inoperable or Iodine Refractory Thyroid Cancer
• Percutaneous Ethanol Injection for Benign Cystic Thyroid Nodules
• Nivolumab Plus Ipilimumab in Thyroid Cancer
• Radiolabelled CCK-2/Gastrin Receptor Analogue for Personalized Theranostic Strategy in Advanced MTC
• Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer
• A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer
• RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
• Pembrolizumab, Chemotherapy, and Radiation Therapy With or Without Surgery in Treating Patients With Anaplastic Thyroid Cancer
• A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
• Insulin Resistance and Metformin Use on Volume of Benign Thyroid Nodules
• Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
• To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
• A Study of LOXO-292 in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer
• UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone
• Treatment of Graves´Ophthalmopathy With Simvastatin (GO-DS)
• A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
• Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer
• Metformin Hydrochloride in Mitigating Side Effects of Radioactive Iodine Treatment in Patients With Differentiated Thyroid Cancer
• Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
• Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer
• Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
• Efficacy of Apatinib in Radioactive Iodine-refractory Differentiated Thyroid Cancer
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors
• The Effects of T4 Versus T4/T3 on Psychological Distress After Total Thyroidectomy in Thyroid Cancer Patients
• CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer
• Effect of Bupivacaine Application on Postthyroidectomy Pain
• A Study to Compare the Safety and Imaging Pattern of Cyclotron-produced Technetium (CTC) vs. Generator-produced Technetium (G-PERT) in People With Thyroid Disorders Who Need Surgery
• Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC)
• A Trial of Lenvatinib (E7080) in Radioiodine (131 I)-Refractory Differentiated Thyroid Cancer in China
• Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy
• Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
• Celecoxib for Thyroid Eye Disease
• The TRUST Trial - CardioVascular Imaging ECHO
• The TRUST Study - CardioVascular Imaging IMT
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
• Study of Apatinib in Patients With Differentiated Thyroid Cancer
• Phase II Study Assessing the Efficacy and Safety of Lenvatinib for Anaplastic Thyroid Cancer
• Potential Role for Carbon Nanoparticles to Guide Central Neck Dissection in Patients With Papillary Thyroid Cancer
• A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safe
• Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer
• A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer
• A Phase 2 Trial of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer (ATC)
• Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma
• Effects of Dexmedetomidine on Cough Response and Postoperative Recovery Quality in Patients Undergoing Thyroid Surgery With General Anesthesia
• Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
• Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)
• Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)
• A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
• Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism
• Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction
• Gemcitabine - Oxaliplatin for Advanced Refractory Thyroid Cancer Patients: a Phase II Study
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
• Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379
• Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)
• The Effect of a New Antioxidant Combination (ASTED) on Moderate to Severe Thyroid Eye Disease
• Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
• Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
• The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer
• 99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
• An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
• Ceritinib in Mutation and Oncogene Directed Therapy in Thyroid Cancer
• Evaluation of Thyroid Stunning From a Diagnostic Dose of I-123
• A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
• An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
• Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy
• Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy
• Prospective, Non-interventional, Post-authorization Safety Study That Includes All Patients Diagnosed as Unresectable Differentiated Thyroid Carcinoma and Treated With Sorafenib
• Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues
• Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
• Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer
• Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study
• Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
• Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients
• 177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.
• Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study
• A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting
• Effect of Perioperative Intravenous Lidocaine Infusion and Magnesium Infusion on the Functional Recovery After General Anesthesia in the Patients Undergoing Thyroid Surgery
• Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
• An Open-label, Multicenter, Phase II Study of Dovitinib in Advanced Thyroid Cancer
• Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
• Observational Study to Evaluate Vandetanib in RET -/+ Patients With Metastatic Medullary Thyroid Cancer
• Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study
• The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
• A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer
• Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
• Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer
• the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake
• Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease
• Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
• Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
• Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer
• Ponatinib for Advanced Medullary Thyroid Cancer
• Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
• Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
• A Multicenter Phase II Pilot Open Label
• Phase II Study of the Optimal Scheme of Administration of Pazopanib in Thyroid Carcinoma
• Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer
• Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery
• Nintedanib(BIBF1120) in Thyroid Cancer
• An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)
• Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
• The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
• Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease
• Efficacy and Safety Study of Sorafenib to Treat Advanced Medullary Thyroid Carcinoma
• A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
• ImmunoTEP for Patients With Medullary Thyroid Carcinoma.
• A Study of E7080 in Subjects With Advanced Thyroid Cancer
• Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy
• Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
• Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
• Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer
• Expanded Access of Cabozantinib in Medullary Thyroid Cancer
• Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid Carcinoma
• Pioglitazone in Thyroid Cancers
• SOM230 Alone or in Combination With RAD001 in Patients With Medullary Thyroid Cancer
• Treatment of Upper Eyelid Retraction Related to Thyroid-associated Ophthalmopathy Using Subconjunctival Triamcinolone Injections
• The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated Ophthalmopathy
• Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
• Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436
• Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
• To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
• Effect of Carum Carvi on Thyroid Hormones and TSH Level
• Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
• To Compare Safety and the General Imaging Pattern of Cyclotron Produced Technetium vs. Generator Produced Technetium in Patients With Thyroid Cancer
• Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
• Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
• Redifferentiation Therapy Using Alpha Lipoic Acid in Thyroid Cancer
• Effect of Metformin on Decrement in Levothyroxin Dose Required for Thyroid Stimulating Hormone (TSH) Suppression in Patients With Differentiated Thyroid Cancer
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC)
• Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Tre
• Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
• Local Triamcinolone Injection in Active Thyroid Orbitopathy
• Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
• Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
• A Phase I/II Trial of Crolibulin (EPC2407) Plus Cisplatin in Adults With Solid Tumors With a Focus on Anaplastic Thyroid Cancer (ATC)
• Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer
• Safety and Efficacy of VB-111 in Subjects With Advanced Differentiated Thyroid Cancer
• Characterization of Thyroid Nodules Using Contrast Enhanced Ultrasound
• Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer
• Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery
• A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
• Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer
• Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer
• Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
• A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
• Combination of Temsirolimus and Sorafenib in the Treatment of Radioactive Iodine Refractory Thyroid Cancer
• Trial of LBH589 in Metastatic Thyroid Cancer
• Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
• Pilot Study to Determine Safety and Efficacy of Orbital Injections of LIPO-102 in Patients With Symptomatic Exophthalmos Associated With Thyroid-related Eye Disease (TED)
• RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
• A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade ), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)
• rAd-p53 Gene Therapy for Advanced Malignant Thyroid Tumors
• Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma
• Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening
• Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer
• Pemetrexed + Paclitaxel in Patients With Recurrent/Advanced Thyroid Cancer
• Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology
• A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
• Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)
• Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
• Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
• Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer
• Clinical Study Investigating the Effect of Sodium Nitroprusside Infusion on Thyroidal Function
• Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer
• Quality of Life, Recombinant TSH (Thyrogen) and Thyroid Cancer
• A Phase 1/2 Study of CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel
• An Initial Study of Lithium in Patients With Medullary Thyroid Cancer
• Nausea and Pain Prophylaxis During Thyroid Surgery
• Selumetinib in Treating Patients With Papillary Thyroid Cancer That Did Not Respond to Radioactive Iodine
• Levothyroxine Treatment in Thyroid Benign Nodular Goiter
• Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
• Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
• Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
• Thyroid Cancer and Sunitinib
• Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
• Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer
• Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
• Dental Safety Profile of High-Dose Radioiodine Therapy
• Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
• An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
• Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer
• Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
• Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery
• Comparison of I-124 PET/CT, F-18 FDG PET/CT & I-123 Whole Body Scintigraphy for Recurrent Thyroid CA
• A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
• Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
• A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
• Lanreotide (Somatuline Autogel) in Thyroid-associated Ophthalmopathy Treatment
• REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
• Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
• Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
• Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I Administration
• Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
• Treatment for Patients With Metastatic Thyroid Cancer
• Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer
• Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer
• Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer
• A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
• Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer
• The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy
• Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
• Thyroid and Glucose and Energy Metabolism
• Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
• Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
• Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine
• Efficacy and Tolerability of ZD6474 in Patients With Thyroid Cancer
• Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
• Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer
• Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer
• Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
• Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
• Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
• Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
• Thalidomide in Treating Patients With Thyroid Cancer
• Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
• Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
• Studies on Tumors of the Thyroid